Cost of allogeneic and autologous blood transfusion in Canada

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 10, 1996, Pages 1501-1508

  Tretiak, Roma ^a,m   Laupacis, Andreas ^b   Rivière, Marc ^a   McKerracher, Krista ^c   Souêtre, Eric ^d   Boshkov, Lynn ^e   Growe, Gershon ^f   Kitts, John ^g   Home, David ^h   Lapointe, Yves ⁱ   Pinkerton, Peter ^j   Whittom, Renaud ^k   Zahir, Muhammad ^l  

^a Benefit Research Group   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c Ortho Biotech   (Canada)

^d Benefit Research Group   (France)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h Oshawa General Hospital   (Canada)

ⁱ NOTRE DAME HOSPITAL   (Canada)

^j SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^k LAVAL UNIVERSITY   (Canada)

^l ROYAL INLAND HOSPITAL   (Canada)

^m NONE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD BANK; BLOOD SAMPLING; BLOOD TRANSFUSION; CANADA; COST; HEALTH CARE COST;

EID: 0030002540     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Perioperative red cell transfusion. NIH Consens Statement 1988; 7 (4): 1-6
2. American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116: 404-406
3. 1993-1994 Statistical Report, Blood Services, Canadian Red Cross Society, Ottawa, 1995
4. Forbes JM, Anderson GF, Anderson GC et al: Blood transfusion costs: a multicentre study. Transfusion 1991; 31: 318-323
5. Lubarsky DA, Hahn C, Bennett DH et al: The hospital cost (fiscal year 1991/92) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University. Anesth Analg 1994; 79: 629-637
6. Sheingold S, Churchill D, Muirhead N et al: The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Soc Sci Med 1992; 34: 983-991
7. Etchason J, Petz L, Keeler E et al: The cost-effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 369-373
8. Ghali WA, Palepu A, Paterson WG: Evaluation of red blood cell transfusion practices with the use of preset criteria. Can Med Assoc J 1994; 150: 1449-1454
9. Guidelines for Economic Evaluations of Pharmaceuticals: Canada, 1st ed, Canadian Coordinating Office for Health Technology Assessment, Ottawa, 1994
10. Drummond MF, Stoddard GL, Torrance GW: Methods for Economic Evaluation of Health Care Programs, Oxford University Press, Toronto, 1987
11. Income Distributions by Size in Canada, 1992 [cat no 13-207], Statistics Canada, Ottawa, 1993: 19
12. Bloom BS, Hillman AL, Fendrick AM et al: A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med 1993; 118: 298-306
13. Hellinger FJ: The lifetime cost of treating a person with HIV. JAMA 1993; 270: 474-478
14. Donahue JG, Munoz A, Ness PM et al: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373
15. Remis RS: Estimation of HIV incidence among repeat blood donors in Montreal: a pilot study. [abstract PO-C21-3111] 9th International Conference on AIDS, Berlin, June 6-11, 1993
16. Laupacis A, Feeny D, Detsky AS et al: How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992; 146: 473-481